FingerprintDive into the research topics of 'Phase II study of triazinate and pyrazofurin in patients with advanced breast cancer previously exposed to cytotoxic chemotherapy'. Together they form a unique fingerprint.
- Sort by
W. C. Nichols, L. K. Kvols, J. N. Ingle, J. H. Edmonson, D. L. Ahmann, J. Rubin, M. J. O'Connell
Research output: Contribution to journal › Article › peer-review